Aim Bulletin

SkinBioTherapeutics CEO resigns

By Iain Gilbert

Date: Friday 13 Feb 2026

(Sharecast News) - Life science business SkinBioTherapeutics said on Friday that chief executive Stuart Ashman has resigned, having been suspended by the board pending an investigation into matters relating to his conduct.
SkinBioTherapeutics said it was undertaking a full investigation, supported by its professional advisors.

Martin Hunt, non-executive chairman of...

Sign up for free or to read the full story

Email this article to a friend

or share it with one of these popular networks:


Article Archive

Top of Page